Drag

Sanofi Cons. Health

Healthcare NSE:SANOFICONR

4331.80INR
33.20 ( 0.77%)

Last update at Feb. 5, 2026, midnight

Day Range

4236.004363.90
LowHigh

52 Week Range

4355.00 5894.50
LowHigh

Fundamentals

  • Previous Close 4298.60
  • Market Cap 101612.67M
  • Volume1,895
  • P/E Ratio 46.61
  • EBITDA 2738.25M
  • Revenue TTM 7981.00M
  • Revenue Per Share TTM 346.53
  • Gross Profit TTM 5928.00M
  • Diluted EPS TTM 94.64

Source: TradingView
The charts and visual representations are sourced from TradingView through embedded widgets. For any issues with chart display, please visit the TradingView website

Financials

Income Statement

Total Revenue
Net Income

Balance Sheet

Total Assets
Total Liabilities

Change in Cash

Breakdown 2024-12-31 2023-12-31
Type yearly yearly
Income before tax 2468.00M 2193.00M
Net income 1810.00M 1649.00M
Total Revenue 7162.00M 5443.00M
Gross Profit 4874.00M 3503.00M
Breakdown 2024-12-31 2023-12-31
Type yearly yearly
Date 2024-12-31 2023-12-31
Total assets 4313.00M 3454.00M
Intangible assets 19.00M 55.00M
Other current assets 58.00M -
Deferred long term liab - -
Non current assets other - -
Breakdown 2024-12-31 2023-12-31
Type yearly yearly
Date 2024-12-31 2023-12-31
Change in Cash 3253.00M 16.00M
Operating Cash 4390.00M -4.00M
Free Cash Flow 4291.00M -44.00M

Peer Comparison

Sector: Healthcare Industry: Drug Manufacturers - General

Company Change Price Market Cap (M) P/E Ratio
NSE:SANOFICONR
Sanofi Cons. Health 		33.20 0.77% 4331.80 101612.67 46.61
GLAXO
GlaxoSmithKline Pharmaceuticals Limited 		37.90 1.57% 2445.00 406354.23 42.58
PFIZER
Pfizer Limited 		-48.50 -1.02% 4695.00 222237.90 26.50
SANOFI
Sanofi India Limited 		-26.20 -0.65% 4010.00 95811.08 26.88
MARKSANS
Marksans Pharma Limited 		2.71 1.53% 179.87 81052.87 23.02

Disclaimer - This information, including any data, is sourced from Unicorn Data Services SAS, trading as EOD Historical Data ("EODHD") on an 'as is' basis, using their API. We cannot guarantee the completeness or validity of the information and data provided on this page, as well as via the API. In some cases, the data may include analyst ratings or recommendations sourced through the EODHD API, which are intended solely for general information purposes.
This information does not consider your personal objectives, financial situation, or needs. Kalkine is not liable for any errors or omissions in the information provided or for any actions taken in reliance on it. You should seek advice from a financial adviser, stockbroker or other professional adviser (including taxation and legal advice) as necessary before acting on this information.